CONMED Corp. (CNMD)
41.67
-0.66
(-1.56%)
USD |
NYSE |
Feb 12, 16:00
41.92
+0.25
(+0.60%)
Pre-Market: 07:48
CONMED Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Johnson & Johnson | -4.485B |
| Bio-Techne Corp. | -5.921M |
| ACADIA Pharmaceuticals, Inc. | -79.35M |
| Agenus, Inc. | 0.076M |
| Alnylam Pharmaceuticals, Inc. | 501.11M |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow | 148.96M |
| Free Cash Flow Per Share (Quarterly) | 1.562 |
| Free Cash Flow to Equity (Quarterly) | 76.57M |
| Free Cash Flow to Firm (Quarterly) | 53.59M |
| Free Cash Flow Yield | 11.50% |